FBIO (Fortress Biotech) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 24, 2026)


FBIO Fortress Biotech Inc FBIO
44 GF Score
Price $3.14
GF Value $1.23
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Fortress Biotech Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Fortress Biotech's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

FBIO vs PTHS, IBIO, NRXS: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Fortress Biotech's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fortress Biotech Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortress Biotech's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Fortress Biotech's Margin of Safety % (DCF FCF Based) falls into.


FBIO
44GF Score
Fortress Biotech Inc FBIO
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fortress Biotech (FBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Fortress Biotech stock appears to be overvalued. The current stock price of $3.14 is trading 155.3% above its estimated GF Value™ of $1.23. GuruFocus considers Fortress Biotech to be Significantly Overvalued.

Key valuation signals for FBIO:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $1.23 vs. price of $3.14 (155.3% above fair value)
  • GF Score™: 44/100 with 7 warning signs

No single metric tells the full story. See the FBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortress Biotech Business Description

Address 1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
44GF Score

Get the complete analysis for FBIO

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.14
Price
$1.23
GF Value